FDA advisory panel unanimously recommends Moderna booster for certain at-risk groups

On Thursday, a Food and Drug Administration advisory committee voted unanimously to recommend Moderna booster shots at a half dose of 50 micrograms for emergency use authorization for similar at-risk groups as the Pfizer booster vaccine. The decision now goes to the FDA, which is expected to make a final decision in the coming days.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting